Shionogi & Co., Ltd. Expected to Earn FY2022 Earnings of $0.86 Per Share (OTCMKTS:SGIOY)

Shionogi & Co., Ltd. (OTCMKTS:SGIOYGet Rating) – Equities researchers at Jefferies Financial Group lowered their FY2022 earnings per share estimates for Shionogi & Co., Ltd. in a research report issued on Monday, April 25th. Jefferies Financial Group analyst S. Barker now anticipates that the company will post earnings of $0.86 per share for the year, down from their prior estimate of $0.95.

Separately, Zacks Investment Research cut Shionogi & Co., Ltd. from a “hold” rating to a “sell” rating in a research note on Saturday, April 16th.

Shares of OTCMKTS SGIOY opened at $13.97 on Thursday. The business’s 50 day moving average is $15.22 and its two-hundred day moving average is $16.16. Shionogi & Co., Ltd. has a 1-year low of $12.13 and a 1-year high of $19.50.

About Shionogi & Co., Ltd. (Get Rating)

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment.

Recommended Stories

Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.